DRUG · Unmapped registry intervention
insulin degludec/insulin aspart
Find medicine records ·
Find other trials using this name
Clinical trial
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily
NCT01814137
Study summary
ClinicalTrials.govA Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
insulin degludec
Normalized identity: insulin degludec View linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
insulin aspart
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
insulin aspart
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Interventions
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
DallasTexas, United States2San DiegoCalifornia, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1IstanbulTurkey (Türkiye)1TacomaWashington, United States1AlbanyNew York, United States1Fort WorthTexas, United States1AnaheimCalifornia, United States1MünsterGermany1PlantationFlorida, United States1Toms RiverNew Jersey, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01814137 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.